article · Life Sciences

Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats

Samar A. Antar
Reda S. Taha
Ahmed S. Abdel Monsef
Ahmad Ahmeda
Amira E. Farage
Laila E. El-Moselhy
Emadeldin M. Kamel
Walied Abdo
Amer M. Abdel Hamid
Mohamed E. Amer
Ayman M. Mahmoud

202167 citationsKafr el-Sheikh University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Eicosanoids and Hypertension Pharmacology
Chronic Kidney Disease and Diabetes
Advanced Glycation End Products research

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.lfs.2021.120260

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.